EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib (NCT03239340) | AstraZeneca | 2018-05-30 |
Track EGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.